Clinical trial
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With…
NCT00090025 · Helsinn Healthcare SA, Industry · Terminated
Key facts
| NCT number | NCT00090025 |
|---|---|
| Title | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors |
| Official title | A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery |
| Lead sponsor | Helsinn Healthcare SA, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Biliary Tract Cancer |
| Intervention type | Drug |
| Interventions | becatecarin, 5-Fluorouracil Plus Leucovorin |
| Enrollment | 248 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Aug 23, 2004 |
| Last update posted | Jan 14, 2009 |
| Countries | Belgium, Canada, France, Germany, Hungary, Italy, Poland, Russia, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: